| P50 | author | Deborah V Novack | Q41140630 |
| | Steven L. Teitelbaum | Q42404516 |
| P2093 | author name string | Judith M Müller | |
| | Roland Schüle | |
| | Ju Chen | |
| | Haibo Zhao | |
| | Bryant Darnay | |
| | F Patrick Ross | |
| | Hideki Kitaura | |
| | Shuting Bai | |
| P2860 | cites work | Distinct molecular mechanism for initiating TRAF6 signalling | Q24302174 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM | Q24515126 |
| | Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. | Q24534150 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | FHL2, a novel tissue-specific coactivator of the androgen receptor | Q24601620 |
| | Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity | Q27635130 |
| | The LIM domain: regulation by association | Q28137861 |
| | Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice | Q28140546 |
| | Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling | Q28141969 |
| | Bone resorption by osteoclasts | Q28145169 |
| | Tumor necrosis factor receptor-associated factors (TRAFs) | Q28199382 |
| | The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein | Q28216196 |
| | Identification of the LIM protein FHL2 as a coactivator of beta-catenin | Q28216665 |
| | The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor | Q28259278 |
| | LIM domains: multiple roles as adapters and functional modifiers in protein interactions | Q28271283 |
| | The LIM domain: from the cytoskeleton to the nucleus | Q28291172 |
| | TRAF6 is a signal transducer for interleukin-1 | Q28291934 |
| | SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts | Q28510858 |
| | TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 |
| | Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption | Q28576916 |
| | Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death | Q28609905 |
| | Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart | Q32065037 |
| | NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis | Q33840418 |
| | Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts | Q33939357 |
| | The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. | Q34184539 |
| | TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. | Q34272380 |
| | Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor | Q34346157 |
| | The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus | Q34543723 |
| | Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. | Q35782350 |
| | Integrins and angiogenesis | Q35962963 |
| | The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis | Q36371653 |
| | FHL2 (SLIM3) is not essential for cardiac development and function | Q39455832 |
| | The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus | Q39646594 |
| | Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis | Q39714931 |
| | c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation | Q39741079 |
| | Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin | Q40486121 |
| | Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism | Q40612839 |
| | The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling | Q41062466 |
| | Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system | Q41749359 |
| | A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function | Q42811314 |
| | A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women | Q46133598 |
| | Marrow Stromal Cells and Osteoclast Precursors Differentially Contribute to TNF- -Induced Osteoclastogenesis In Vivo | Q58085384 |
| | The structure of the human LIM protein ACT gene and its expression in tumor cell lines | Q73938567 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2742-2751 | |
| P577 | publication date | 2005-09-22 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner | |
| P478 | volume | 115 | |